There are two components Cannabis Laboratory tests have been able to stop the virus that causes Govit-19 from invading healthy human cells. The experiment was carried out by a team of researchers from Oregon State University in the United States. Study Published Monday in Education Magazine Journal of Natural Products.
SARS-CoV-2 corona virus is also known as surface spike “Spicule protein” (Where Spikes) Are necessary for the virus to penetrate into human cells and infect people. Oregon researchers have discovered two components of hemp (or Cannabis Sativa), Which is varied Cannabis Low tetrahydrocannabinol (THC), the plant’s main psychoactive substance, Spikes Prevents SARS-CoV-2 from invading cells.
The components in question are acids called CBGA and CBDA.
“These cannabinoids are abundant in hemp and many hemp extracts.” Explained Researcher Richard von Freeman, who led the study, in a presentation of his work. V.One Freeman notes that the components can be “taken orally” and “have a good protective profile” in humans. They are already precursors to products such as CBD (cannabidiol) used in various food products, body lotions and cosmetics.
“It simply came to our notice then [do vírus] In cells such as hemp acids, SARS-CoV-2 can be used to prevent infection, ”explains the researcher. Integrates or Global Hemp Innovation Center From university.
Be effective against variations
Hemp components have also been shown to be effective against some variants of the new corona virus. “Our investigation shows that hemp components are equally effective against variants of SARS-CoV-2, including variant B.1.1.7 first detected in the UK and variant B.1.351 first detected in the south. Africa, ”said Van Freeman. The two types mentioned are known as alpha and beta respectively.
Van Freeman acknowledges that acid-resistant variants of hemp may be present, but hopes that combining vaccines with CBDA and CBGA treatments will make infection more difficult.
The team of researchers suggests that there may be other substances capable of blocking the spike protein of SARS-CoV-2. Preliminary tests with licorice indicate the possibility of another compound, which prevents the virus from infecting human cells, although Van Freeman’s team needs more funding to complete laboratory tests.